Overview

Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)

Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This is a pharmacokinetic and pharmacodynamic study evaluating glyburide, metformin, and combination treatment for gestational diabetes mellitus.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborators:
Indiana University School of Medicine
RTI International
University of Pittsburgh
University of Texas
University of Washington
Treatments:
Glyburide
Metformin